8-KMaterial AgreementsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Material Agreement (May 4, 2006)

Filed May 4, 2006For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on May 3, 2006, reporting an event on May 1, 2006, concerning changes to its executive and director compensation structures. The Board of Directors authorized a reduction in compensation for non-employee directors, decreasing their quarterly stock option grants from 8,000 to 5,000 shares. This move signals a potential shift in how the company incentivizes its board members and may reflect a response to market conditions or corporate governance considerations. Additionally, the Compensation and Human Resources Committee approved a revised Stock Appreciation Rights Award Agreement for officers under the 2002 Stock Incentive Plan. While the details of the revised agreement are not fully disclosed in this 8-K beyond its existence, it indicates an update to the incentive compensation framework for key executives. Investors should monitor future filings for specific details on the revised SAR agreement and its potential impact on executive compensation and shareholder value.

Key Highlights

  • 1Reduction in quarterly stock option grants for non-employee directors from 8,000 to 5,000 shares, effective May 1, 2006.
  • 2Approval of a revised Stock Appreciation Rights (SAR) Award Agreement for officers under the 2002 Stock Incentive Plan.
  • 3The revised SAR agreement is effective as of May 2, 2006.
  • 4These changes relate to the company's incentive compensation programs for both directors and officers.
  • 5The filing was made on May 3, 2006, with the earliest reported event date of May 1, 2006.
  • 6The primary focus of this 8-K is on executive and director compensation adjustments.

Frequently Asked Questions

This 8-K filing from UnitedHealth Group Inc. is primarily to report on adjustments made to its executive and director compensation plans. Specifically, it details a reduction in stock option grants for non-employee directors and an update to the stock appreciation rights agreement for officers.

The reduction in quarterly stock option grants for non-employee directors from 8,000 to 5,000 shares is a governance decision that lowers the equity awarded to board members. This could be interpreted as a cost-saving measure, a response to shareholder feedback on compensation, or a strategic adjustment to align director incentives differently. Its direct impact on UNH's financial performance is likely to be minor, but it reflects on corporate governance practices.

Stock Appreciation Rights (SARs) are a form of executive compensation that gives an employee the right to receive a cash payment or additional stock equivalent to the increase in the company's stock price over a specified period. The revision of the SAR agreement for officers indicates that UnitedHealth Group is updating the terms, conditions, or performance metrics associated with these awards, likely to better align executive incentives with company strategy or market practices.

The revised Form of Stock Appreciation Rights Award Agreement for Officers under the Company's 2002 Stock Incentive Plan is filed as Exhibit 10.1 to this 8-K. Investors can refer to this exhibit for the specific terms and conditions of the amended agreement.